LIVECAST Markets Briefs Calendar Search

Research

AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar Search AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive Account

Live News EARNINGS FLASH H impact Sep 29, 2026, 11:01 AM UTC

IOVA - Iovance Biotherapeutics Raises Full Year 2026 Revenue Guidance to $410 to $420 Million

SquawkNews Newsroom

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

IOVA

Related stories

Tigo Energy (TYGO) shares plunge 36.76% on forecast cut tied to delayed EG4 partnership Tigo Energy Inc. shares fell 36.76% on August 5, 2026, after the company announced it was cutting its 2026 income projections by about 20.8% due to significant delays in its partne M impact | EARNINGS | Sep 30, 2026, 03:02 PM UTC Galaxy Cosmos Mezz reports H1 net profit at €2.1 million M impact | EARNINGS | Sep 30, 2026, 02:33 PM UTC cBrain raises 2026 EBT margin outlook to 22%-26% cBrain raised its 2026 EBT margin outlook to 22%-26% from 20%-25%. Revenue growth outlook for 2026 was maintained at 10%-15%. M impact | EARNINGS | Sep 30, 2026, 02:31 PM UTC Nektar Therapeutics says rezpegaldesleukin shows early biomarker response in Phase 2b REZOLVE-AD Nektar reported new biomarker results from its Phase 2b REZOLVE-AD study of rezpegaldesleukin in moderate-to-severe atopic dermatitis, presented at EADV Congress 2026, and said the M impact | EARNINGS | Sep 30, 2026, 02:31 PM UTC Nomad Compute PLC Reports H1 2026 Loss, Raises £3.124M for AI Strategy Nomad Compute PLC reported an unaudited H1 2026 group loss of £185,604 and cash of £1.904M. The company raised approximately £3.124M gross via a placing to fund an edge AI strategy M impact | EARNINGS | Sep 30, 2026, 02:31 PM UTC Iovance Biotherapeutics Stock Pauses After Hitting New 52-Week High: What's Going On? Shares of Iovance Biotherapeutics Inc. (NASDAQ: IOVA ) are trading flat Wednesday morning, taking a breather after Tuesday’s surge which pushed the stock to a new 52-week high. Her H impact | LIVE | Sep 30, 2026, 02:28 PM UTC

SQUAWK/NEWS

Live financial news for traders. Read the headline on screen or hear it through LiveCast while you stay on the trade.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

Product

Open LiveCast
Plans & Pricing
Institutional API
How LiveCast Works
Live Markets
Session Briefs
RSS Feed
Calendar
Search
Instrument directory

Research

Macro
Politics
Prediction Markets
AI Market Assistant
News Archive

For Traders

Market Movers
US Stocks
Why News Moves Markets
News for Traders
How to Trade the News
What Is an Audio Squawk?
Policy Calendar

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

Legal

Privacy Policy
Terms of Use

© 2026 SquawkNews SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.